• Body dysmorphic disorder symptoms [ Time Frame: Measured at Months 6 and 9 ] [ Designated as safety issue: No ]
  

• Functioning and life satisfaction [ Time Frame: Measured at Months 6 and 9 ] [ Designated as safety issue: No ]
  
• Depressive symptoms [ Time Frame: Measured at Months 6 and 9 ] [ Designated as safety issue: Yes ]
  
• Anxiety symptoms [ Time Frame: Measured at Months 6 and 9 ] [ Designated as safety issue: No ]
  

BDD is a disease that involves preoccupation with imagined or minor physical flaws. The condition often begins in adolescence and, if left untreated, can cause significant social, emotional, and occupational distress. Within the last decade, BDD has received increased attention, and various modes of treatment have been utilized and evaluated. CBT has been found to be a more effective form of treatment than other types of psychotherapy. In this study, we have created a new CBT treatment manual and are currently implementing it to evaluate its effectiveness in patients with BDD. The utility of this manual for different populations will also be evaluated, and adherence and competence measures to assess CBT delivery will be developed.

This study will last 24 weeks. Participants will be randomly assigned (like the flip of a coin) to either start CBT treatment immediately or to a waitlist group, which would require a 3-month wait without treatment before beginning treatment for this study. Participants have a 50-50 chance of being in either group. Participants will receive a total of 22 sessions of individual, manual-based CBT. The CBT sessions will occur weekly during the course of the study. During the sessions, participants will receive education about BDD and CBT, engage in activities that help them confront their BDD, learn new ways of thinking about body image, and learn relapse prevention techniques. Self-report scales will be used to assess participants.